14th Jun 2025 · SEBI-Registered Analyst
SHREE DHANRAKSHA MONEY WEALTH · 14th Jun 2025
Biocon – Pharma / Biotech
BIOCON
Also broke above its 200‑DMA, reflecting technical strength Structural drivers like increasing biologics demand and biosimilar approvals support long-term momentum in healthcare.
#WatchOutFor#FundamentalViews#PersonalFinance#MacroViews
232 likes·67 comments